• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem High Test Results (2457)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 10/27/2021
Event Type  Injury  
Manufacturer Narrative
The customer's meter and test strips were requested for investigation.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.The reporter's meter and test strips were provided for investigation.However, the customer's returned strip vial was empty with no more useable test strips.Therefore, the reporter's returned meter was tested with retention strips and retention controls.Testing results (qc range = 2.3 - 3.5 inr): qc 1: 2.9 inr, qc 2: 2.9 inr, qc 3: 2.9 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.Per product labeling: "coaguchek uses human recombinant thromboplastin.Therefore, comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." occupation - the occupation is patient/consumer.
 
Event Description
It was alleged that a patient had a blood clot while using coaguchek xs meter serial number (b)(4).It was also alleged that the patient received a questionable result when testing with the meter.The actual date and time of the alleged event are unknown.The patient went to the emergency room for an alleged blood clot in her left leg and a strained muscle in her right leg.The patient was not admitted to the hospital.It was alleged that the treating physician did not know what caused the blood clot but was concerned about the variance observed between meter and laboratory tests.The patient had two ultrasound procedures performed.The patient confirmed that the blood clot in her left leg was a deep venous thrombosis (dvt).At an unknown date and time, a venous sample collected from the patient was tested in the laboratory using an unknown method, resulting in an alleged value of 1.6 inr.The patient's warfarin dosage was believed to have been increased based on this value, however, this is not known for sure.The warfarin dosage increase was used to treat the patient's blood clot.The patient reportedly received no other treatment for the blood clot.At an unknown time on (b)(6) 2021, a sample from the patient was tested using the meter, resulting in an alleged value of 2.7 inr.No therapeutic changes were made based on this value.Upon review of the meter's patient result memory, it was determined the date and time of the meter had been set incorrectly by the patient.This meter measurement was alleged to have occurred on (b)(6) 2021, but the meter recorded a date of (b)(6) 2021.The patient's therapeutic range is 2.0 - 3.0 inr.The patient's testing interval is bi-weekly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key12916365
MDR Text Key286596530
Report Number1823260-2021-03560
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/31/2022
Device Catalogue Number04625374160
Device Lot Number51508621
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/03/2021
Initial Date FDA Received12/02/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
COLESTIPOL HCL; ISOSORBIDE MONONITRATE (TABLETS); KLOR-CON; LOSARTAN / HYDROCHLOROTHIAZIDE; SERTRALINE; TIADYLT ER; WARFARIN SODIUM
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient SexFemale
Patient Weight119 KG
-
-